304 related articles for article (PubMed ID: 37812379)
1. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.
van Poelgeest E; Seppala L; Bahat G; Ilhan B; Mair A; van Marum R; Onder G; Ryg J; Fernandes MA; Cherubini A; Denkinger M; Eidam A; Egberts A; Gudmundsson A; Koçak FÖK; Soulis G; Tournoy J; Masud T; Wehling M; van der Velde N;
Eur Geriatr Med; 2023 Dec; 14(6):1195-1209. PubMed ID: 37812379
[TBL] [Abstract][Full Text] [Related]
2. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
3. Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus.
Tan ECK; Sluggett JK; Johnell K; Onder G; Elseviers M; Morin L; Vetrano DL; Wastesson JW; Fastbom J; Taipale H; Tanskanen A; Bell JS;
J Am Med Dir Assoc; 2018 Mar; 19(3):193-199. PubMed ID: 29361432
[TBL] [Abstract][Full Text] [Related]
4. Deprescribing in Older Adults With Cardiovascular Disease.
Krishnaswami A; Steinman MA; Goyal P; Zullo AR; Anderson TS; Birtcher KK; Goodlin SJ; Maurer MS; Alexander KP; Rich MW; Tjia J;
J Am Coll Cardiol; 2019 May; 73(20):2584-2595. PubMed ID: 31118153
[TBL] [Abstract][Full Text] [Related]
5. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
[TBL] [Abstract][Full Text] [Related]
6. Methods to reduce prescribing errors in elderly patients with multimorbidity.
Lavan AH; Gallagher PF; O'Mahony D
Clin Interv Aging; 2016; 11():857-66. PubMed ID: 27382268
[TBL] [Abstract][Full Text] [Related]
7. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy in elderly people.
Dovjak P
Wien Med Wochenschr; 2022 Apr; 172(5-6):109-113. PubMed ID: 35006518
[TBL] [Abstract][Full Text] [Related]
9. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
10. The value of deprescribing in older adults with dementia: a narrative review.
Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
[No Abstract] [Full Text] [Related]
11. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
Chou J; Tong M; Brandt NJ
J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
[TBL] [Abstract][Full Text] [Related]
12. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
[TBL] [Abstract][Full Text] [Related]
13. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
Todd A; Jansen J; Colvin J; McLachlan AJ
BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop.
Schwartz JB; Schmader KE; Hanlon JT; Abernethy DR; Gray S; Dunbar-Jacob J; Holmes HM; Murray MD; Roberts R; Joyner M; Peterson J; Lindeman D; Tai-Seale M; Downey L; Rich MW
J Am Geriatr Soc; 2019 Feb; 67(2):371-380. PubMed ID: 30536694
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark.
Schiøtz ML; Frølich A; Jensen AK; Reuther L; Perrild H; Petersen TS; Kornholt J; Christensen MB
Pharmacol Res Perspect; 2018 Dec; 6(6):e00431. PubMed ID: 30386624
[TBL] [Abstract][Full Text] [Related]
16. Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial.
Jungo KT; Meier R; Valeri F; Schwab N; Schneider C; Reeve E; Spruit M; Schwenkglenks M; Rodondi N; Streit S
BMC Fam Pract; 2021 Jun; 22(1):123. PubMed ID: 34157981
[TBL] [Abstract][Full Text] [Related]
17. [Deprescribing of inappropriate medication in primary care].
Høj K; Mygind A; Livbjerg S; Bro F
Ugeskr Laeger; 2019 Jun; 181(24):. PubMed ID: 31267949
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing deprescribing habits among geriatricians.
Ní Chróinín D; Ní Chróinín C; Beveridge A
Age Ageing; 2015 Jul; 44(4):704-8. PubMed ID: 25758409
[TBL] [Abstract][Full Text] [Related]
19. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.
McCarthy C; Clyne B; Boland F; Moriarty F; Flood M; Wallace E; Smith SM;
PLoS Med; 2022 Jan; 19(1):e1003862. PubMed ID: 34986166
[TBL] [Abstract][Full Text] [Related]
20. Factors which influence the deprescribing decisions of community-living older adults and GPs in Australia.
Gillespie R; Mullan J; Harrison L
Health Soc Care Community; 2022 Nov; 30(6):e6206-e6216. PubMed ID: 36165345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
